Approval · Notice of Compliance 339 · 2002
CEFACLOR CAPSULES: Notice of Compliance 339
Issued November 8, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 339
- Date
- November 8, 2002
- Company
- Ivax Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antibiotic
- Canadian reference product
- CECLOR (Eli Lilly And Company)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFACLOR CAPSULES | 02237729 | Cancelled Post Market |
| CEFACLOR CAPSULES | 02237730 | Cancelled Post Market |